Hybrid scaffold composed of hydrogel/3D-framework and its application as a dopamine delivery system
SCIE
SCOPUS
- Title
- Hybrid scaffold composed of hydrogel/3D-framework and its application as a dopamine delivery system
- Authors
- Kang, KS; Lee, SI; Hong, JM; Lee, JW; Cho, HY; Son, JH; Paek, SH; Cho, DW
- Date Issued
- 2014-02-10
- Publisher
- ELSEVIER SCIENCE BV
- Abstract
- Cell-based drug delivery systems (DDSs) have been increasingly exploited because cells can be utilized as a continuous drug delivering system to produce therapeutic molecules over a more extended period compared to the simple drug carriers. Although hydrogels have many advantages for this application, their mechanical properties are generally not desirable to structurally protect implanted cells. Here, we present a three-dimensional (3D) hybrid scaffold with a combination of a 3D framework and a hydrogel to enhance the mechanical properties without chemically altering the transport properties of the hydrogel. Based on the 3D Ormocomp scaffold (framework) fabricated by projection-based microstereolithography with defined parameters, we developed a 3D hybrid scaffold by injection of the mixture of cells and the alginate gel into the internal space of the framework. This hybrid scaffold showed the improved mechanical strength and the framework in the scaffold played the role of an adhesion site for the encapsulated cells during the culture period. Additionally, we confirmed its protection of exogenous human cells from acute immune rejection in a mouse model. Eventually, we demonstrated the feasibility of applying this hybrid scaffold to the treatment of Parkinson's disease as a cell-based DDS. Dopamine released from the 3D hybrid scaffolds encapsulating dopamine-secreting cells for 8 weeks suggested its clinical applicability. Further study on its long-term efficacy is necessary for the clinical applicability of this 3D hybrid scaffold for the treatment of Parkinson's disease. (C) 2013 Elsevier B.V. All rights reserved.
- Keywords
- Dopamine; Drug delivery system; Hydrogel; Parkinson' s disease; Scaffold; DEEP BRAIN-STIMULATION; ALGINATE HYDROGELS; PARKINSONS-DISEASE; SECRETING CELLS; CROSS-LINKING; GROWTH; GEL; NEUROPROTECTION; ENCAPSULATION; FABRICATION
- URI
- https://oasis.postech.ac.kr/handle/2014.oak/14619
- DOI
- 10.1016/J.JCONREL.2013.12.002
- ISSN
- 0168-3659
- Article Type
- Article
- Citation
- JOURNAL OF CONTROLLED RELEASE, vol. 175, page. 10 - 16, 2014-02-10
- Files in This Item:
- There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.